Cullinan Therapeutics, Inc. Common Stock (CGEM) is a publicly traded Healthcare sector company. As of May 21, 2026, CGEM trades at $13.88 with a market cap of $913.88M and a P/E ratio of 0.00. CGEM moved +0.95% today. Year to date, CGEM is +43.44%; over the trailing twelve months it is +81.39%. Its 52-week range spans $5.68 to $17.98. Analyst consensus is strong buy with an average price target of $30.00. Rallies surfaces CGEM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Cullinan Therapeutics, Inc. Common Stock (CGEM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CGEM moved +0.95% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $13.88 |
| Market Cap | $913.88M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.98 |
| 52-Week Low | $5.68 |
| Volume | 11 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-219.88M |
| Gross Margin | 0.00% |
11 analysts cover CGEM: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.00.